• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三级淋巴结构,历史再评价。

Tertiary lymphoid structures, a historical reappraisal.

机构信息

Department of Translational Biomedicine and Neuroscience, University of Bari Medical School, Bari, Italy.

出版信息

Tissue Cell. 2024 Feb;86:102288. doi: 10.1016/j.tice.2023.102288. Epub 2023 Dec 10.

DOI:10.1016/j.tice.2023.102288
PMID:38101028
Abstract

Tertiary lymphoid structures (TLSs) are accumulations of lymphoid cells within non-lymphoid organs that share the cellular compartments, spatial organization, vasculature, chemokines, and function with secondary lymphoid organs, especially lymph nodes. TLSs are organized into a separate T cell and B cell compartments which contain germinal centers with follicular dendritic cells. In most cases, TLSs contain Peripheral Node addressin (PNAD) expressing high endothelial venules (HEVs). TLSs have been described in various mouse models of inflammation and are associated with a wide range of autoimmune diseases. Other than these, TLSs have been described in chronic allograft rejection and cancer.

摘要

三级淋巴结构 (TLSs) 是指在非淋巴器官内聚集的淋巴样细胞,它们具有与次级淋巴器官(尤其是淋巴结)相同的细胞区室、空间组织、脉管系统、趋化因子和功能。TLSs 被组织成一个独立的 T 细胞和 B 细胞区室,其中包含含有滤泡树突状细胞的生发中心。在大多数情况下,TLSs 含有表达外周淋巴结地址素 (PNAD) 的高内皮静脉 (HEV)。在各种炎症的小鼠模型中都描述了 TLSs,并与广泛的自身免疫性疾病有关。除此之外,TLSs 还在慢性移植物排斥反应和癌症中被描述。

相似文献

1
Tertiary lymphoid structures, a historical reappraisal.三级淋巴结构,历史再评价。
Tissue Cell. 2024 Feb;86:102288. doi: 10.1016/j.tice.2023.102288. Epub 2023 Dec 10.
2
Defining High Endothelial Venules and Tertiary Lymphoid Structures in Cancer.定义癌症中的高内皮微静脉和三级淋巴结构。
Methods Mol Biol. 2018;1845:99-118. doi: 10.1007/978-1-4939-8709-2_7.
3
Immunological potential of tertiary lymphoid structures surrounding the primary tumor in gastric cancer.胃癌原发灶周围三级淋巴结构的免疫潜能。
Int J Oncol. 2020 Jul;57(1):171-182. doi: 10.3892/ijo.2020.5042. Epub 2020 Apr 8.
4
B cells in tertiary lymphoid structures are associated with favorable prognosis in gastric cancer.三级淋巴结构中的B细胞与胃癌的良好预后相关。
J Surg Res. 2017 Jul;215:74-82. doi: 10.1016/j.jss.2017.03.033. Epub 2017 Apr 1.
5
High endothelial venules present in lymphoid cell accumulations in thyroids affected by autoimmune disease: a study in men and BB rats of functional activity and development.自身免疫性疾病累及的甲状腺中淋巴样细胞聚集处存在的高内皮微静脉:一项关于功能活性和发育的男性及BB大鼠研究。
J Clin Endocrinol Metab. 1989 Apr;68(4):744-51. doi: 10.1210/jcem-68-4-744.
6
Evolution of ectopic lymphoid neogenesis and in situ autoantibody production in autoimmune nonobese diabetic mice: cellular and molecular characterization of tertiary lymphoid structures in pancreatic islets.自身免疫性非肥胖型糖尿病小鼠异位淋巴样组织生成和原位自身抗体产生的演变:胰岛中三级淋巴样结构的细胞和分子特征。
J Immunol. 2010 Sep 15;185(6):3359-68. doi: 10.4049/jimmunol.1001836. Epub 2010 Aug 16.
7
Artery tertiary lymphoid organs contribute to innate and adaptive immune responses in advanced mouse atherosclerosis.动脉三级淋巴器官有助于晚期动脉粥样硬化小鼠的先天和适应性免疫反应。
Circ Res. 2014 May 23;114(11):1772-87. doi: 10.1161/CIRCRESAHA.114.301137.
8
Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances.疾病中的三级淋巴结构:免疫机制与治疗进展。
Signal Transduct Target Ther. 2024 Aug 28;9(1):225. doi: 10.1038/s41392-024-01947-5.
9
High endothelial venules (HEVs) in immunity, inflammation and cancer.高内皮小静脉(HEVs)在免疫、炎症和癌症中的作用。
Angiogenesis. 2021 Nov;24(4):719-753. doi: 10.1007/s10456-021-09792-8. Epub 2021 May 6.
10
Regulation, Maintenance, and Remodeling of High Endothelial Venules in Homeostasis, Inflammation, and Cancer.稳态、炎症和癌症中高内皮微静脉的调节、维持与重塑
Curr Opin Physiol. 2023 Dec;36. doi: 10.1016/j.cophys.2023.100705. Epub 2023 Aug 18.

引用本文的文献

1
Cell-Based Therapies for Solid Tumors: Challenges and Advances.实体瘤的细胞疗法:挑战与进展
Int J Mol Sci. 2025 Jun 9;26(12):5524. doi: 10.3390/ijms26125524.